Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zivo Bioscience's operating cash flow for the twelve months ending Sep 30, 2025 was -$3.08M. For fiscal 2024 it was -$4.31M. The highest annual figure on record is -$1.29M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$4.31M | – |
| FY2023 | Dec 31, 2023 | -$5.80M | – |
| FY2022 | Dec 31, 2022 | -$7.10M | – |
| FY2021 | Dec 31, 2021 | -$6.80M | – |
| FY2020 | Dec 31, 2020 | -$2.59M | – |
| FY2019 | Dec 31, 2019 | -$3.71M | – |
| FY2018 | Dec 31, 2018 | -$5.01M | – |
| FY2017 | Dec 31, 2017 | -$4.24M | – |
| FY2016 | Dec 31, 2016 | -$2.54M | – |
| FY2015 | Dec 31, 2015 | -$2.30M | – |
| FY2014 | Dec 31, 2014 | -$2.74M | – |
| FY2013 | Dec 31, 2013 | -$2.99M | – |
| FY2012 | Dec 31, 2012 | -$1.77M | – |
| FY2011 | Dec 31, 2011 | -$1.29M | – |
| FY2010 | Dec 31, 2010 | -$1.44M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -$266.56K | – |
| Q2 FY2025 | Jun 30, 2025 | -$476.41K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.43M | – |
| Q4 FY2024 | Dec 31, 2024 | -$905.72K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$623.65K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.70M | – |
| Q4 FY2023 | Dec 31, 2023 | -$715.73K | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.97M | – |
| Q2 FY2023 | Jun 30, 2023 | -$985.67K | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.49M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.31M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.86M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.90M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.05M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.05M | – |
| Q4 FY2020 | Dec 31, 2020 | -$901.48K | – |
| Q3 FY2020 | Sep 30, 2020 | -$564.12K | – |
| Q2 FY2020 | Jun 30, 2020 | -$339.75K | – |
| Q1 FY2020 | Mar 31, 2020 | -$783.07K | – |
| Q4 FY2019 | Dec 31, 2019 | -$651.33K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$576.23K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.23M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.78M | – |
| Q1 FY2018 | Mar 31, 2018 | -$874.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.36M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.23M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.12M | – |
| Q1 FY2017 | Mar 31, 2017 | -$529.49K | – |
| Q4 FY2016 | Dec 31, 2016 | -$819.85K | – |
| Q3 FY2016 | Sep 30, 2016 | -$440.45K | – |
| Q2 FY2016 | Jun 30, 2016 | -$525.00K | – |
| Q1 FY2016 | Mar 31, 2016 | -$758.18K | – |
| Q4 FY2015 | Dec 31, 2015 | -$486.53K | – |
See a number that looks wrong?